Autonomic Nervous System Drugs Practice Questions

Q: Which of the following medications should be used for pheochromocytoma-associated hypertension after phenoxybenzamine is started?

Propranolol. **Explanation:** In the management of **Pheochromocytoma**, the sequence of adrenergic blockade is critical. The correct approach is to initiate **Alpha-blockade first** (typically with Phenoxybenzamine), followed by **Beta-blockade** (e.g., Propranolol). **Why Propranolol is the correct answer:** Pheochromocytomas secrete large amounts of catecholamines (epinephrine and norepinephrine). If a beta-blocker like Propranolol is given alone or before alpha-blockade, it inhibits $\beta_2$-mediated vasodilation in the skeletal muscle vasculature. This leaves the $\alpha_1$ receptors unopposed to the massive circulating catecholamines, leading to severe, paradoxical vasoconstriction and a life-threatening **hypertensive crisis**. Once alpha-blockade is established (usually after 7–10 days), Propranolol is added to control tachycardia and arrhythmias. **Analysis of Incorrect Options:** * **A, C, & D (Amlodipine, Nifedipine, Diltiazem):** These are Calcium Channel Blockers (CCBs). While CCBs can be used as add-on therapy or in patients who cannot tolerate alpha-blockers, they are not the standard "next step" in the classic pharmacological preparation sequence for surgery. Propranolol is specifically required to counteract the reflex tachycardia caused by Phenoxybenzamine. **NEET-PG High-Yield Pearls:** * **Rule of 10s:** 10% bilateral, 10% malignant, 10% extra-adrenal (Paraganglioma), 10% pediatric, 10% familial. * **Drug of Choice:** **Phenoxybenzamine** (Irreversible, non-selective alpha-blocker) is the preferred preoperative drug. * **Sequence:** Always **Alpha before Beta** to prevent hypertensive crisis. * **Metyrosine:** Can be used in malignant or inoperable cases to inhibit tyrosine hydroxylase (the rate-limiting enzyme in catecholamine synthesis).

Q: Which Alpha 1 blocker is used for Benign Prostatic Hyperplasia (BHP)?

Tamsulosin. **Explanation:** **1. Why Tamsulosin is Correct:** Tamsulosin is a selective **$\alpha_{1A}$ receptor antagonist**. In the human prostate and bladder neck, the predominant subtype is $\alpha_{1A}$. By specifically blocking these receptors, Tamsulosin relaxes the smooth muscles of the prostatic urethra and bladder neck, thereby improving urine flow in patients with Benign Prostatic Hyperplasia (BPH). Its high selectivity for the 1A subtype means it has minimal effect on the $\alpha_{1B}$ receptors found in blood vessels, resulting in a lower incidence of orthostatic hypotension compared to non-selective blockers. **2. Why Other Options are Incorrect:** * **Prazosin:** This is a non-selective $\alpha_1$ blocker ($\alpha_{1A} = \alpha_{1B}$). While it can be used for BPH, it is primarily used as an antihypertensive. It carries a high risk of "first-dose phenomenon" (severe postural hypotension). * **Oxazosin (Doxazosin):** Similar to Prazosin, it is a non-selective $\alpha_1$ blocker. Although FDA-approved for BPH, it is less preferred than Tamsulosin because it requires dose titration and significantly affects blood pressure. * **Tolazoline (misspelled as Dolazoline):** This is a non-selective $\alpha$ blocker (blocks both $\alpha_1$ and $\alpha_2$) with some histamine-like actions. It is primarily used in persistent pulmonary hypertension of the newborn, not BPH. **3. High-Yield Clinical Pearls for NEET-PG:** * **Uroselectivity:** Tamsulosin and Silodosin (most selective) are "uroselective" $\alpha_{1A}$ blockers. * **Side Effect:** A unique side effect of Tamsulosin is **Floppy Iris Syndrome**, which is critical to note before cataract surgery. * **Retrograde Ejaculation:** This is a common side effect of highly selective $\alpha_{1A}$ blockers like Silodosin and Tamsulosin. * **Timing:** Unlike non-selective blockers, Tamsulosin does not require bedtime dosing as it has minimal effects on blood pressure.

Q: Which of the following is least useful in the management of overactive bladder?

Duloxetine. **Explanation:** The management of **Overactive Bladder (OAB)**, characterized by urgency and frequency, primarily targets the **M3 muscarinic receptors** on the detrusor muscle to prevent involuntary contractions. **Why Duloxetine is the correct answer:** Duloxetine is a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI). It increases the tone of the external urethral sphincter by increasing the activity of the pudendal nerve (Onuf’s nucleus). Therefore, it is used in the management of **Stress Urinary Incontinence (SUI)**—leakage during coughing or sneezing—rather than OAB. It is considered "least useful" here because it does not address detrusor overactivity. **Why the other options are incorrect:** * **Oxybutynin (Option A):** A classic non-selective antimuscarinic. It is effective for OAB but limited by systemic side effects like dry mouth and constipation. * **Tolterodine (Option B):** A potent antimuscarinic with relative selectivity for the bladder over salivary glands, making it better tolerated than oxybutynin for OAB. * **Darifenacin (Option C):** A highly **M3-selective** antagonist. By specifically targeting the M3 receptors on the detrusor, it minimizes M1/M2-related side effects (like cognitive impairment or tachycardia). **High-Yield Clinical Pearls for NEET-PG:** * **First-line for OAB:** Behavioral therapy followed by Antimuscarinics (M3 blockers). * **Mirabegron:** A **β3-agonist** used for OAB; it relaxes the detrusor during the filling phase. It is a preferred alternative if antimuscarinics are contraindicated (e.g., in narrow-angle glaucoma). * **Trospium:** A quaternary ammonium antimuscarinic that does not cross the blood-brain barrier, making it ideal for OAB patients with pre-existing dementia. * **Drug of choice for Nocturnal Enuresis:** Desmopressin (oral/nasal).

Q: Sympathetic system has adrenergic nerve endings at all sites except?

Blood vessels in skeletal muscles. ### Explanation The sympathetic nervous system typically utilizes **norepinephrine** as its primary neurotransmitter at postganglionic nerve endings (Adrenergic transmission). However, there are specific exceptions where the sympathetic fibers are **cholinergic** (releasing Acetylcholine). **Why Option B is Correct:** In most mammals, the sympathetic innervation to the **blood vessels of skeletal muscles** consists of **Sympathetic Cholinergic Vasodilator (SCV)** fibers. These fibers release Acetylcholine (ACh) which acts on M3 receptors to cause vasodilation, increasing blood flow during the "fight or flight" response. Note: While circulating adrenaline also causes vasodilation via $\beta_2$ receptors, the actual nerve endings in this specific site are cholinergic, not adrenergic. **Analysis of Incorrect Options:** * **A. Heart:** Postganglionic sympathetic fibers release norepinephrine, which acts on $\beta_1$ receptors to increase heart rate (chronotropy) and force of contraction (inotropy). * **C. Eye:** Sympathetic fibers release norepinephrine to act on $\alpha_1$ receptors of the radial pupillary dilator muscle, causing mydriasis (dilation). **High-Yield Clinical Pearls for NEET-PG:** 1. **The Two Exceptions:** There are two main sites where the sympathetic system is **Cholinergic**: * **Sweat glands** (Eccrine glands for thermoregulation). * **Blood vessels of skeletal muscles** (in certain physiological states). 2. **Adrenal Medulla:** It is technically a modified sympathetic ganglion. The preganglionic fibers reaching it are cholinergic (releasing ACh). 3. **Dopaminergic Exception:** Sympathetic supply to **renal mesenteric blood vessels** involves Dopamine (D1 receptors) at certain nerve endings. 4. **Memory Aid:** "Sympathetic = Adrenergic" EXCEPT for **S**weat and **S**keletal muscle vessels (The "Double S" exception).

Q: Beta2 adrenergic receptor stimulating drugs are used in which of the following conditions?

Bronchial asthma. **Explanation:** **1. Why Bronchial Asthma is Correct:** $\beta_2$ adrenergic receptors are primarily located in the smooth muscles of the bronchi. Stimulation of these receptors activates the Gs-protein-adenylyl cyclase-cAMP pathway, leading to **bronchodilation**. In bronchial asthma, where there is reversible airway obstruction, $\beta_2$ agonists (like Salbutamol or Salmeterol) are the mainstay of treatment to relieve bronchospasm and improve airflow. **2. Why the Other Options are Incorrect:** * **Cardiac Asthma:** This is not true asthma; it is wheezing caused by pulmonary edema due to **Left Ventricular Failure (LVF)**. Treatment focuses on diuretics (Furosemide) and vasodilators, not $\beta_2$ stimulants, which could worsen the condition by increasing heart rate. * **Hypertension:** $\beta_2$ stimulants are not used here. In fact, $\beta$ **blockers** (like Atenolol) or $\alpha$ blockers are used to lower blood pressure. * **Angina Pectoris:** $\beta_2$ stimulation can cause reflex tachycardia, which increases myocardial oxygen demand and worsens angina. Treatment involves $\beta$ **blockers** (to reduce heart rate/demand) or Nitrates. **3. NEET-PG High-Yield Pearls:** * **SABA vs. LABA:** Short-Acting $\beta_2$ Agonists (Salbutamol, Terbutaline) are used for acute attacks. Long-Acting $\beta_2$ Agonists (Salmeterol, Formoterol) are used for maintenance/prophylaxis. * **Uterine Effect:** $\beta_2$ receptors are also present in the uterus. $\beta_2$ agonists (e.g., **Ritodrine, Isoxsuprine**) act as tocolytics to delay premature labor. * **Metabolic Side Effect:** A common side effect of $\beta_2$ agonists is **hypokalemia** (due to stimulation of Na+/K+ ATPase, driving potassium into cells) and muscle tremors.

Q: Propranolol can be used in all of the following conditions EXCEPT:

Variant angina. **Explanation:** **Variant Angina (Prinzmetal Angina)** is the correct answer because Propranolol, a non-selective beta-blocker, is **contraindicated** in this condition. Variant angina is caused by coronary artery vasospasm rather than atherosclerosis. By blocking $eta_2$ receptors (which mediate vasodilation), Propranolol leaves $\alpha_1$ receptors unopposed. This leads to exaggerated vasoconstriction, potentially worsening the spasm and causing myocardial ischemia [5]. **Why other options are incorrect:** * **Thyrotoxicosis:** Propranolol is the drug of choice to control symptomatic tachycardia and tremors. It also uniquely inhibits the peripheral conversion of $T_4$ to the more active $T_3$ [1]. * **Migraine:** Propranolol is a first-line agent for the **prophylaxis** of migraine (not acute attacks) due to its lipophilic nature and ability to cross the blood-brain barrier [1]. * **Hypertension:** While no longer first-line for uncomplicated hypertension, beta-blockers remain effective, especially in patients with co-existing conditions like stable angina or post-myocardial infarction [2]. **High-Yield Clinical Pearls for NEET-PG:** 1. **Drug of Choice for Variant Angina:** Calcium Channel Blockers (CCBs) like Diltiazem or Nitrates. 2. **Lipophilicity:** Propranolol is highly lipid-soluble, explaining its CNS side effects (vivid dreams/nightmares) and its efficacy in migraine and essential tremors [3]. 3. **Contraindications:** Avoid Propranolol in **Asthma/COPD** (due to $eta_2$ blockade causing bronchospasm), **Decompensated Heart Failure**, and **Diabetes Mellitus** (masks hypoglycemic tachycardia) [4].

Q: Which of the following is NOT an endogenous catecholamine?

Isoprenaline. **Explanation:** The distinction between endogenous and synthetic catecholamines is a high-yield concept in autonomic pharmacology. **Catecholamines** are chemical compounds consisting of a catechol nucleus (a benzene ring with two adjacent hydroxyl groups) and an amine side chain. **Why Isoprenaline is the correct answer:** **Isoprenaline (Isoproterenol)** is a **synthetic** catecholamine. While it possesses the catechol nucleus, it is not produced naturally within the human body. It is a potent, non-selective $\beta$-receptor agonist ($\beta_1$ and $\beta_2$) with negligible $\alpha$-receptor activity, used clinically for bradyarrhythmias and heart block. **Why the other options are incorrect:** The body synthesizes three primary endogenous catecholamines via the tyrosine-phenylalanine pathway: * **Dopamine:** The immediate precursor to Noradrenaline; acts as a neurotransmitter in the CNS and renal vasculature. * **Noradrenaline (Norepinephrine):** The primary neurotransmitter of postganglionic sympathetic nerves. * **Adrenaline (Epinephrine):** The primary hormone secreted by the adrenal medulla. **NEET-PG High-Yield Pearls:** 1. **Biosynthesis Sequence:** Tyrosine $\rightarrow$ L-Dopa $\rightarrow$ Dopamine $\rightarrow$ Noradrenaline $\rightarrow$ Adrenaline. 2. **Rate-limiting enzyme:** Tyrosine hydroxylase. 3. **Metabolism:** Endogenous catecholamines are metabolized by **MAO** (Intracellular) and **COMT** (Extracellular). The major end-metabolite excreted in urine is **VMA (Vanillylmandelic acid)**; elevated levels are diagnostic for Pheochromocytoma. 4. **Synthetic Non-catecholamines:** Drugs like Ephedrine and Amphetamine lack the catechol hydroxyl groups, making them resistant to COMT, orally active, and able to cross the blood-brain barrier.

Q: Dorzolamide is a:

Topically applied ocular carbonic anhydrase inhibitor. **Explanation:** **Dorzolamide** is a potent, highly specific inhibitor of the enzyme **Carbonic Anhydrase (Type II)**. In the eye, carbonic anhydrase is essential for the production of aqueous humor by the ciliary body epithelium. By inhibiting this enzyme, Dorzolamide reduces the secretion of aqueous humor, thereby lowering intraocular pressure (IOP). It is specifically designed for **topical application** as an ophthalmic solution to avoid the systemic side effects (like metabolic acidosis or electrolyte imbalance) associated with oral carbonic anhydrase inhibitors like Acetazolamide. **Analysis of Incorrect Options:** * **Option A:** Second-generation sulfonylureas (e.g., Glibenclamide, Glipizide) are used for Type 2 Diabetes. While Dorzolamide shares a sulfonamide structure, it has no hypoglycemic activity. * **Option B:** Although Dorzolamide is a sulfonamide derivative, it lacks clinically significant antimicrobial activity. Topical sulfonamide antibacterials include drugs like Sulfacetamide. * **Option C:** Luminal amoebicides (e.g., Diloxanide furoate, Iodoquinol) act within the bowel lumen to treat intestinal amoebiasis; they are unrelated to carbonic anhydrase inhibition. **High-Yield Clinical Pearls for NEET-PG:** * **Indications:** Primarily used in Open-Angle Glaucoma and Ocular Hypertension. * **Side Effects:** The most common side effect is a **bitter taste (dysgeusia)** following application due to drainage through the nasolacrimal duct. It can also cause local stinging and superficial punctate keratitis. * **Contraindication:** Avoid in patients with known **sulfonamide hypersensitivity**. * **Brinzolamide** is another topical carbonic anhydrase inhibitor; it is often preferred over Dorzolamide as it causes less ocular stinging.

Q: Which beta-blocker possesses intrinsic sympathomimetic activity?

Celiprolol. ### Explanation **Correct Answer: D. Celiprolol** **Understanding the Concept: Intrinsic Sympathomimetic Activity (ISA)** Beta-blockers with ISA are **partial agonists**. While they bind to beta-receptors and block the effects of endogenous catecholamines (like epinephrine), they also cause low-level activation of the receptor. This results in less resting bradycardia and less peripheral vasoconstriction compared to pure antagonists. **Celiprolol** is a unique third-generation cardioselective ($\beta_1$) blocker that also possesses **$\beta_2$ agonist activity** (ISA) and weak $\alpha_2$ blocking properties. This makes it particularly useful in patients with reactive airway disease or peripheral vascular disease where pure beta-blockade might be contraindicated. **Analysis of Incorrect Options:** * **A. Propranolol:** A prototype non-selective beta-blocker ($\beta_1 + \beta_2$). It is a **pure antagonist** and lacks ISA. It is highly lipid-soluble and frequently used for migraine prophylaxis and portal hypertension. * **B. Atenolol:** A second-generation **cardioselective ($\beta_1$) blocker**. It is hydrophilic, has no ISA, and is primarily excreted by the kidneys. * **C. Bisoprolol:** A highly **$\beta_1$-selective blocker** without ISA. It is a mainstay in the management of chronic heart failure (along with Carvedilol and Metoprolol succinate). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for ISA:** "**P**in **P**ale **C**ats" → **P**indolol (strongest ISA), **P**enbutolol, **C**eliprolol, **A**cebutolol, **L**abetalol, **E**panolol. * **Clinical Advantage:** Beta-blockers with ISA are preferred in patients prone to **bradycardia**, as they maintain a higher resting heart rate. * **Celiprolol Speciality:** It is often highlighted in exams for its "vasodilatory" beta-blocker status due to its $\beta_2$ agonism.

Question 1

Which of the following medications should be used for pheochromocytoma-associated hypertension after phenoxybenzamine is started?

Accepted Answer

Propranolol

Answer

Amlodipine

Answer

Nifedipine

Answer

Diltiazem

Question 2

Which Alpha 1 blocker is used for Benign Prostatic Hyperplasia (BHP)?

Accepted Answer

Tamsulosin

Answer

Prazosin

Answer

Oxazosin

Answer

Dolazoline

Question 3

Which of the following is least useful in the management of overactive bladder?

Accepted Answer

Duloxetine

Answer

Oxybutynin

Answer

Tolterodine

Answer

Darifenacin

Question 4

Sympathetic system has adrenergic nerve endings at all sites except?

Accepted Answer

Blood vessels in skeletal muscles

Answer

Heart

Answer

Eye

Answer

None of the above

Question 5

Beta2 adrenergic receptor stimulating drugs are used in which of the following conditions?

Accepted Answer

Bronchial asthma

Answer

Cardiac asthma

Answer

Hypertension

Answer

Angina pectoris

Question 6

Propranolol can be used in all of the following conditions EXCEPT:

Accepted Answer

Variant angina

Answer

Thyrotoxicosis

Answer

Migraine

Answer

Hypertension

Question 7

Which of the following is NOT an endogenous catecholamine?

Accepted Answer

Isoprenaline

Answer

Dopamine

Answer

Noradrenaline

Answer

Adrenaline

Question 8

Which of the following is NOT a metabotropic receptor?

Accepted Answer

Beta receptor for norepinephrine

Answer

GABA receptor

Answer

Acetylcholine receptor

Answer

Alpha receptor for norepinephrine

Question 9

Dorzolamide is a:

Accepted Answer

Topically applied ocular carbonic anhydrase inhibitor

Answer

Second generation sulfonylurea hypoglycaemic

Answer

Topical sulfonamide antibacterial

Answer

Luminal amoebicide

Question 10

Which beta-blocker possesses intrinsic sympathomimetic activity?

Accepted Answer

Celiprolol

Answer

Propranolol

Answer

Atenolol

Answer

Bisoprolol

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?